PWV was also correlated with age, systolic blood pressure, and C-reactive protein.

Reducing systolic blood pressure is standard of care for secondary stroke prevention.

In pre-approval studies, ProAmatine increased standing systolic blood pressure for one minute.

The latter association remained significant after adjustment for systolic blood pressure and age.

Conclusion: Liraglutide had greater hypoglycemic, weight-reducing and systolic blood pressure-lowering effects than placebo.

Elevated systolic blood pressure accounted for the majority of inadequate control.

Stented patients were younger, had higher systolic blood pressure and more severe ARAS.

Remission was significantly associated with captopril therapy and control of systolic blood pressure.

Age and systolic blood pressure correlated with plaque extents in both the aortas.

This mainly reflected a decrease in the systolic blood pressure in the elderly.

Decaffeinated coffee intake was not associated with mean systolic blood pressure.

Standing systolic blood pressure was significantly lower in the isradipine group.

Drivers for decreased risk were improvements in blood cholesterol and systolic blood pressure.

We also examined the association between postdonation systolic blood pressure and graft failure.

During treatments systolic blood pressure was significantly increased in conscious rats.

Among patients with DM, increasing age and systolic blood pressure were associated with CKD.